- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential
Global Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential
Results
11
0 new
Stocks with plenty of capacity to fund future growth
11 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NBIX | US$135.42 | 6.9% | 5.4% | US$13.7b | US$165.04 | PE35.5x | E30.4% | n/a | ||
INCY | US$68.84 | 0.4% | 9.5% | US$13.3b | US$79.38 | PE408.3x | E46.9% | n/a | ||
CORT | US$51.40 | -7.2% | 56.9% | US$5.4b | US$74.90 | PE38.3x | E41.4% | n/a | ||
KRYS | US$164.83 | 0.7% | 33.1% | US$4.7b | US$207.78 | PE90.5x | E41.2% | n/a | ||
ADMA | US$17.40 | -6.4% | 310.4% | US$4.1b | US$24.25 | PE60.4x | E30.5% | n/a | ||
ACAD | US$16.87 | -2.3% | -46.3% | US$2.8b | US$25.11 | PE21.8x | E28.0% | n/a | ||
VCEL | US$56.50 | -1.7% | 62.6% | US$2.8b | US$64.25 | PE786x | E51.6% | n/a | ||
LGND | US$114.64 | -1.9% | 60.3% | US$2.2b | US$144.00 | PE47.9x | E26.9% | n/a | ||
HRMY | US$34.28 | 5.8% | 6.7% | US$2.0b | US$53.88 | PE15.9x | E34.5% | n/a | ||
CDXC | US$5.49 | -10.3% | 278.6% | US$420.3m | US$7.96 | PE283x | E81.8% | n/a | ||
BSEM | US$14.44 | -16.1% | 157.9% | US$240.0m | US$32.50 | PE15.1x | E33.8% | n/a |
Page 1 of 1